My name is Adil Daud. I’m a medical oncologist. I work at the University of California, San Francisco, where I direct melanoma research and the melanoma program.
Archive | Melanoma News
Skin-cancer rates have spiked among young women; experts advise limiting sun exposure, tanning beds
New research shows that skin-cancer rates have surged among young women, likely because they use tanning beds, but health experts warn that exposure to the sun’s harmful ultraviolet (UV) rays puts us all at risk, so it’s important to always take precautions when out in the sun.
Posted in Melanoma News, Clare Oliver, Sunbed Articles
Melanoma: Progression After Immunotherapy
Jeffrey S. Weber, MD, PhD: Let’s transition to the elephant in the room. We’ve heard great things about single-agent PD-1 [programmed cell death protein 1] blockade, ipilimumab-nivolumab, BRAF/MEK—multiple combinations, all frontline therapy.
Posted in Melanoma News, Health Professionals, Video Reports
Combination Therapy in Mutated Melanoma
The big impact of MEK inhibitors has been 2-fold. One is that it delays resistance, which you know, you have this additional blockade for cells that have somehow managed to live without BRAF.
Posted in Melanoma News, Health Professionals, Video Reports
